Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
The content you intended to share did not come through. Please paste the material about prostate cancer treatments and bone health, and I will summarize it as requested.
Prostate cancer affects tens of thousands of men every year. One of the most common treatments—Androgen Deprivation Therapy (ADT)—effectively slows tumor growth by lowering testosterone levels. While life-saving, ADT carries a well-documented risk of bone loss. Understanding this risk and following protective protocols can help you maintain stronger bones throughout treatment.
Androgen Deprivation Therapy prostate cancer bone loss is a critical concern because testosterone plays a key role in bone remodeling. When testosterone drops:
Several studies show men on ADT can lose 2–8% of bone mineral density (BMD) in the first year alone. Over time, this can translate into fragile bones and a higher chance of breaks from everyday activities.
Bones are living tissue that constantly renews itself. When resorption (breakdown) outpaces formation, overall strength declines. In prostate cancer patients, fractures are more than painful inconveniences:
Protecting your bones from the start of ADT is as important as monitoring your cancer markers.
Below are evidence-based steps to help offset bone loss during prostate cancer treatment. Always discuss any new regimen with your healthcare team.
Adequate intake of key nutrients supports bone remodeling:
Exercise stimulates bone formation and preserves muscle mass:
Aim for at least 30 minutes of moderate exercise most days. Work with a physical therapist if you’re new to structured exercise.
Your doctor may prescribe bone-strengthening therapies:
Follow administration guidelines closely and report any jaw pain or unusual thigh pain, which can be rare side effects.
Small changes can yield big benefits:
In select cases, intermittent ADT or lower-dose regimens may be an option:
Discuss risks and benefits with a medical oncologist familiar with your overall health status.
Beyond bone loss, ADT can cause:
Keep a log of any new or worsening symptoms. A “free, online symptom check, using the doctor approved Ubie Symptom Checker” can help you track concerns before your next appointment.
Immediate medical attention is warranted if you experience:
For all other questions—no matter how small—they deserve a discussion. Your best bone health plan comes from a team approach.
Androgen Deprivation Therapy is a cornerstone of prostate cancer care, but it comes with a trade-off: increased bone loss. By combining:
you can significantly reduce the risk of osteoporosis and fractures.
Staying proactive about bone health doesn’t add stress; it empowers you. Keep open communication with your oncology and primary care teams. And remember, you’re not alone—many resources and specialists are ready to help you protect your skeletal strength throughout your prostate cancer journey.
Disclaimer: This information is educational and does not replace medical advice. Always speak to a doctor about any serious or life-threatening concerns and before making changes to your treatment plan.
(References)
* Dhillon T, Waxman J. Osteoporosis and prostate cancer. Br J Cancer. 2003 Sep 1;89(5):779-80. doi: 10.1038/sj.bjc.6601191. PMID: 12942104; PMCID: PMC2394483.
* Tuck S, Francis R. Testosterone, bone and osteoporosis. Front Horm Res. 2009;37:123-132. doi: 10.1159/000176049. PMID: 19011293.
* Rizzoli R, Yasothan U, Kirkpatrick P. Denosumab. Nat Rev Drug Discov. 2010 Aug;9(8):591-2. doi: 10.1038/nrd3244. PMID: 20671758.
* Bogado CE, Zanchetta MB, Boailchuk JA, Massari FE, Zanchetta JR. Denosumab: What's new? Curr Osteoporos Rep. 2011 Mar;9(1):12-9. doi: 10.1007/s11914-010-0040-1. PMID: 21132405.
* Walsh JS, Eastell R. Osteoporosis in men. Nat Rev Endocrinol. 2013 Nov;9(11):637-45. doi: 10.1038/nrendo.2013.171. Epub 2013 Sep 10. PMID: 24019112.
* Adler RA. Prostate cancer treated with androgen deprivation therapy has consequences for bone. Endocrine. 2014 Apr;45(3):339-40. doi: 10.1007/s12020-013-0113-x. Epub 2013 Dec 24. PMID: 24366636.
* Grey A. Osteoporosis and Fracture Risk in Men with Prostate Cancer. Eur Urol. 2016 Jun;69(6):1026-7. doi: 10.1016/j.eururo.2015.12.036. Epub 2015 Dec 31. PMID: 26749094.
* Tuck SP. Prostate Cancer and Fracture: Identifying at-Risk Groups. J Clin Densitom. 2017 Apr-Jun;20(2):196-197. doi: 10.1016/j.jocd.2016.06.009. Epub 2016 Jul 20. PMID: 27448496.
* Savaiano DA, Hutkins RW. Yogurt, cultured fermented milk, and health: a systematic review. Nutr Rev. 2021 Apr 7;79(5):599-614. doi: 10.1093/nutrit/nuaa013. PMID: 32447398; PMCID: PMC8579104.
* Dell'Aquila E, Armento G, Iuliani M, Simonetti S, D'Onofrio L, Zeppola T, Madaudo C, Russano M, Citarella F, Ribelli G, Pantano F, Vincenzi B, Tonini G, Santini D. Denosumab for cancer-related bone loss. Expert Opin Biol Ther. 2020 Nov;20(11):1261-1274. doi: 10.1080/14712598.2020.1814731. Epub 2020 Sep 9. PMID: 32835531.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.